Inhibition of Naja naja venom hyaluronidase by plant-derived bioactive components and polysaccharides
The inhibitory effect of several bioactive compounds on the activity of hyaluronidase enzyme purified from Naja naja venom was investigated in vitro. Compounds were found to inhibit the hyaluronidase activity dose dependently. Among glycosaminoglycans, heparin, heparan sulfate, and dermatan sulfate...
Gespeichert in:
Veröffentlicht in: | Biochemistry (Moscow) 2005-08, Vol.70 (8), p.948-952 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 952 |
---|---|
container_issue | 8 |
container_start_page | 948 |
container_title | Biochemistry (Moscow) |
container_volume | 70 |
creator | Girish, K S Kemparaju, K |
description | The inhibitory effect of several bioactive compounds on the activity of hyaluronidase enzyme purified from Naja naja venom was investigated in vitro. Compounds were found to inhibit the hyaluronidase activity dose dependently. Among glycosaminoglycans, heparin, heparan sulfate, and dermatan sulfate showed maximum inhibition compared to chondroitin sulfates. Different molecular forms of chitosan inhibit the enzyme, and inhibition appears to depend on the chain length. In addition, plant-derived bioactive compounds also inhibited the activity of hyaluronidase dose dependently. Among those tested, aristolochic acid, indomethacin, quercetin, curcumin, tannic acid, and flavone exhibited inhibition, with aristolochic acid and quercetin completely inhibiting the enzyme activity. It is concluded that the inhibitors of hyaluronidase could be used as potent first aid agents in snakebite therapy. Furthermore, these inhibitors not only reduce the local tissue damage but also retard the easy diffusion of systemic toxins and hence increase survival time. |
doi_str_mv | 10.1007/s10541-005-0207-z |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68670873</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2137716141</sourcerecordid><originalsourceid>FETCH-LOGICAL-c392t-bb5508811660a5ca8f01e8abe837caaeefacec88b2a2819a52af9bcef9f2230c3</originalsourceid><addsrcrecordid>eNpdkU1r3DAQhkVpaTZpf0AvRfTQm9KRFNnysYR-BEJ7ac9iJI9ZLbbkSnZg8-vrZRcKvcwHvO_wMg9j7yTcSoD2U5Vg7qQAMAIUtOL5BdvJBqzQcAcv2Q4AGqG6trti17UetlVBp1-zK9koqYzRO0YPaR99XGJOPA_8Bx6Qp1N5opQnvj_iuJacYo-VuD_yecS0iJ5KfKKe-5gxLNvIQ57mnCgtlWPq-ZzHY8UQ9lhiT_UNezXgWOntpd-w31-__Lr_Lh5_fnu4__wogu7UIrw3BqyVsmkATUA7gCSLnqxuAyLRgIGCtV6hsrJDo3DofKChG5TSEPQN-3i-O5f8Z6W6uCnWQOMWmvJaXWObFmyrN-GH_4SHvJa0ZXOtAQOy604ieRaFkmstNLi5xAnL0UlwJwDuDMBtANwJgHvePO8vh1c_Uf_Pcfm4_gtVGYNo</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>750501993</pqid></control><display><type>article</type><title>Inhibition of Naja naja venom hyaluronidase by plant-derived bioactive components and polysaccharides</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Girish, K S ; Kemparaju, K</creator><creatorcontrib>Girish, K S ; Kemparaju, K</creatorcontrib><description>The inhibitory effect of several bioactive compounds on the activity of hyaluronidase enzyme purified from Naja naja venom was investigated in vitro. Compounds were found to inhibit the hyaluronidase activity dose dependently. Among glycosaminoglycans, heparin, heparan sulfate, and dermatan sulfate showed maximum inhibition compared to chondroitin sulfates. Different molecular forms of chitosan inhibit the enzyme, and inhibition appears to depend on the chain length. In addition, plant-derived bioactive compounds also inhibited the activity of hyaluronidase dose dependently. Among those tested, aristolochic acid, indomethacin, quercetin, curcumin, tannic acid, and flavone exhibited inhibition, with aristolochic acid and quercetin completely inhibiting the enzyme activity. It is concluded that the inhibitors of hyaluronidase could be used as potent first aid agents in snakebite therapy. Furthermore, these inhibitors not only reduce the local tissue damage but also retard the easy diffusion of systemic toxins and hence increase survival time.</description><identifier>ISSN: 0006-2979</identifier><identifier>EISSN: 1608-3040</identifier><identifier>DOI: 10.1007/s10541-005-0207-z</identifier><identifier>PMID: 16212553</identifier><language>eng</language><publisher>United States: Springer Nature B.V</publisher><subject>Alkaloids - pharmacology ; Animals ; Anti-Inflammatory Agents - pharmacology ; Antioxidants - pharmacology ; Bioactive compounds ; Chitosan - pharmacology ; Curcumin - pharmacology ; Dexamethasone - pharmacology ; Dose-Response Relationship, Drug ; Elapid Venoms - enzymology ; Elapidae ; Enzymatic activity ; Flavonoids - pharmacology ; Glycosaminoglycans - pharmacology ; Heparan sulfate ; Hyaluronoglucosaminidase - antagonists & inhibitors ; Hyaluronoglucosaminidase - metabolism ; Indomethacin - pharmacology ; Plant Preparations - chemistry ; Plant Preparations - pharmacology ; Polysaccharides - pharmacology ; Quercetin - pharmacology ; Reserpine - pharmacology ; Saccharides ; Snake bites ; Sulfates ; Tannic acid ; Toxins</subject><ispartof>Biochemistry (Moscow), 2005-08, Vol.70 (8), p.948-952</ispartof><rights>MAIK "Nauka/Interperiodica" 2005</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c392t-bb5508811660a5ca8f01e8abe837caaeefacec88b2a2819a52af9bcef9f2230c3</citedby><cites>FETCH-LOGICAL-c392t-bb5508811660a5ca8f01e8abe837caaeefacec88b2a2819a52af9bcef9f2230c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16212553$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Girish, K S</creatorcontrib><creatorcontrib>Kemparaju, K</creatorcontrib><title>Inhibition of Naja naja venom hyaluronidase by plant-derived bioactive components and polysaccharides</title><title>Biochemistry (Moscow)</title><addtitle>Biochemistry (Mosc)</addtitle><description>The inhibitory effect of several bioactive compounds on the activity of hyaluronidase enzyme purified from Naja naja venom was investigated in vitro. Compounds were found to inhibit the hyaluronidase activity dose dependently. Among glycosaminoglycans, heparin, heparan sulfate, and dermatan sulfate showed maximum inhibition compared to chondroitin sulfates. Different molecular forms of chitosan inhibit the enzyme, and inhibition appears to depend on the chain length. In addition, plant-derived bioactive compounds also inhibited the activity of hyaluronidase dose dependently. Among those tested, aristolochic acid, indomethacin, quercetin, curcumin, tannic acid, and flavone exhibited inhibition, with aristolochic acid and quercetin completely inhibiting the enzyme activity. It is concluded that the inhibitors of hyaluronidase could be used as potent first aid agents in snakebite therapy. Furthermore, these inhibitors not only reduce the local tissue damage but also retard the easy diffusion of systemic toxins and hence increase survival time.</description><subject>Alkaloids - pharmacology</subject><subject>Animals</subject><subject>Anti-Inflammatory Agents - pharmacology</subject><subject>Antioxidants - pharmacology</subject><subject>Bioactive compounds</subject><subject>Chitosan - pharmacology</subject><subject>Curcumin - pharmacology</subject><subject>Dexamethasone - pharmacology</subject><subject>Dose-Response Relationship, Drug</subject><subject>Elapid Venoms - enzymology</subject><subject>Elapidae</subject><subject>Enzymatic activity</subject><subject>Flavonoids - pharmacology</subject><subject>Glycosaminoglycans - pharmacology</subject><subject>Heparan sulfate</subject><subject>Hyaluronoglucosaminidase - antagonists & inhibitors</subject><subject>Hyaluronoglucosaminidase - metabolism</subject><subject>Indomethacin - pharmacology</subject><subject>Plant Preparations - chemistry</subject><subject>Plant Preparations - pharmacology</subject><subject>Polysaccharides - pharmacology</subject><subject>Quercetin - pharmacology</subject><subject>Reserpine - pharmacology</subject><subject>Saccharides</subject><subject>Snake bites</subject><subject>Sulfates</subject><subject>Tannic acid</subject><subject>Toxins</subject><issn>0006-2979</issn><issn>1608-3040</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNpdkU1r3DAQhkVpaTZpf0AvRfTQm9KRFNnysYR-BEJ7ac9iJI9ZLbbkSnZg8-vrZRcKvcwHvO_wMg9j7yTcSoD2U5Vg7qQAMAIUtOL5BdvJBqzQcAcv2Q4AGqG6trti17UetlVBp1-zK9koqYzRO0YPaR99XGJOPA_8Bx6Qp1N5opQnvj_iuJacYo-VuD_yecS0iJ5KfKKe-5gxLNvIQ57mnCgtlWPq-ZzHY8UQ9lhiT_UNezXgWOntpd-w31-__Lr_Lh5_fnu4__wogu7UIrw3BqyVsmkATUA7gCSLnqxuAyLRgIGCtV6hsrJDo3DofKChG5TSEPQN-3i-O5f8Z6W6uCnWQOMWmvJaXWObFmyrN-GH_4SHvJa0ZXOtAQOy604ieRaFkmstNLi5xAnL0UlwJwDuDMBtANwJgHvePO8vh1c_Uf_Pcfm4_gtVGYNo</recordid><startdate>20050801</startdate><enddate>20050801</enddate><creator>Girish, K S</creator><creator>Kemparaju, K</creator><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7TM</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>88I</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7N</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20050801</creationdate><title>Inhibition of Naja naja venom hyaluronidase by plant-derived bioactive components and polysaccharides</title><author>Girish, K S ; Kemparaju, K</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c392t-bb5508811660a5ca8f01e8abe837caaeefacec88b2a2819a52af9bcef9f2230c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Alkaloids - pharmacology</topic><topic>Animals</topic><topic>Anti-Inflammatory Agents - pharmacology</topic><topic>Antioxidants - pharmacology</topic><topic>Bioactive compounds</topic><topic>Chitosan - pharmacology</topic><topic>Curcumin - pharmacology</topic><topic>Dexamethasone - pharmacology</topic><topic>Dose-Response Relationship, Drug</topic><topic>Elapid Venoms - enzymology</topic><topic>Elapidae</topic><topic>Enzymatic activity</topic><topic>Flavonoids - pharmacology</topic><topic>Glycosaminoglycans - pharmacology</topic><topic>Heparan sulfate</topic><topic>Hyaluronoglucosaminidase - antagonists & inhibitors</topic><topic>Hyaluronoglucosaminidase - metabolism</topic><topic>Indomethacin - pharmacology</topic><topic>Plant Preparations - chemistry</topic><topic>Plant Preparations - pharmacology</topic><topic>Polysaccharides - pharmacology</topic><topic>Quercetin - pharmacology</topic><topic>Reserpine - pharmacology</topic><topic>Saccharides</topic><topic>Snake bites</topic><topic>Sulfates</topic><topic>Tannic acid</topic><topic>Toxins</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Girish, K S</creatorcontrib><creatorcontrib>Kemparaju, K</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database (Proquest)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest Science Journals</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Biochemistry (Moscow)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Girish, K S</au><au>Kemparaju, K</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Inhibition of Naja naja venom hyaluronidase by plant-derived bioactive components and polysaccharides</atitle><jtitle>Biochemistry (Moscow)</jtitle><addtitle>Biochemistry (Mosc)</addtitle><date>2005-08-01</date><risdate>2005</risdate><volume>70</volume><issue>8</issue><spage>948</spage><epage>952</epage><pages>948-952</pages><issn>0006-2979</issn><eissn>1608-3040</eissn><abstract>The inhibitory effect of several bioactive compounds on the activity of hyaluronidase enzyme purified from Naja naja venom was investigated in vitro. Compounds were found to inhibit the hyaluronidase activity dose dependently. Among glycosaminoglycans, heparin, heparan sulfate, and dermatan sulfate showed maximum inhibition compared to chondroitin sulfates. Different molecular forms of chitosan inhibit the enzyme, and inhibition appears to depend on the chain length. In addition, plant-derived bioactive compounds also inhibited the activity of hyaluronidase dose dependently. Among those tested, aristolochic acid, indomethacin, quercetin, curcumin, tannic acid, and flavone exhibited inhibition, with aristolochic acid and quercetin completely inhibiting the enzyme activity. It is concluded that the inhibitors of hyaluronidase could be used as potent first aid agents in snakebite therapy. Furthermore, these inhibitors not only reduce the local tissue damage but also retard the easy diffusion of systemic toxins and hence increase survival time.</abstract><cop>United States</cop><pub>Springer Nature B.V</pub><pmid>16212553</pmid><doi>10.1007/s10541-005-0207-z</doi><tpages>5</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0006-2979 |
ispartof | Biochemistry (Moscow), 2005-08, Vol.70 (8), p.948-952 |
issn | 0006-2979 1608-3040 |
language | eng |
recordid | cdi_proquest_miscellaneous_68670873 |
source | MEDLINE; SpringerLink Journals - AutoHoldings |
subjects | Alkaloids - pharmacology Animals Anti-Inflammatory Agents - pharmacology Antioxidants - pharmacology Bioactive compounds Chitosan - pharmacology Curcumin - pharmacology Dexamethasone - pharmacology Dose-Response Relationship, Drug Elapid Venoms - enzymology Elapidae Enzymatic activity Flavonoids - pharmacology Glycosaminoglycans - pharmacology Heparan sulfate Hyaluronoglucosaminidase - antagonists & inhibitors Hyaluronoglucosaminidase - metabolism Indomethacin - pharmacology Plant Preparations - chemistry Plant Preparations - pharmacology Polysaccharides - pharmacology Quercetin - pharmacology Reserpine - pharmacology Saccharides Snake bites Sulfates Tannic acid Toxins |
title | Inhibition of Naja naja venom hyaluronidase by plant-derived bioactive components and polysaccharides |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T17%3A20%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Inhibition%20of%20Naja%20naja%20venom%20hyaluronidase%20by%20plant-derived%20bioactive%20components%20and%20polysaccharides&rft.jtitle=Biochemistry%20(Moscow)&rft.au=Girish,%20K%20S&rft.date=2005-08-01&rft.volume=70&rft.issue=8&rft.spage=948&rft.epage=952&rft.pages=948-952&rft.issn=0006-2979&rft.eissn=1608-3040&rft_id=info:doi/10.1007/s10541-005-0207-z&rft_dat=%3Cproquest_cross%3E2137716141%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=750501993&rft_id=info:pmid/16212553&rfr_iscdi=true |